Guardant Health Inc (GH)

Jun 3, 2025, 2:56 PM EDT - 2 days ago

Why Is Cancer Diagnostic Guardant Health Stock Trading Higher On Tuesday?

Jun 3, 2025, 8:05 AM EDT - 2 days ago

FDA Grants Breakthrough Device Designation to Guardant Health's Shield Multi-Cancer Detection (MCD) Test

Jun 2, 2025, 8:05 AM EDT - 3 days ago

National Comprehensive Cancer Network (NCCN) Updates Colorectal Cancer Screening Guidelines to Include Shield Blood-Based Screening

Jun 2, 2025, 7:00 AM EDT - 3 days ago

SERENA-6 Phase III Trial Demonstrates Clinical Value of Guardant360 CDx Test to Detect Emergence of Endocrine Resistance and Inform a Switch in Therapy Before Radiological Disease Progression in Advanced Breast Cancer

May 31, 2025, 8:05 AM EDT - 5 days ago

In Largest Molecular Residual Disease (MRD) Study in Colon Cancer, Guardant Reveal Testing Prior to Chemotherapy Provides Robust Stratification for Risk of Disease Recurrence and Survival to Enable Timely Treatment Decisions

May 27, 2025, 5:30 PM EDT - 9 days ago

Guardant Health Introduces Nearly a Dozen Groundbreaking Smart Liquid Biopsy Applications for Guardant360 Liquid Test

May 22, 2025, 5:05 PM EDT - 14 days ago

Guardant Health and Collaborators to Present Over 19 Studies Demonstrating Role of Liquid Biopsy in Advancing Precision Oncology at 2025 ASCO Annual Meeting

May 21, 2025, 8:05 AM EDT - 15 days ago

Guardant Health Introduces Comprehensive Immunohistochemistry Testing for Solid Tumors

May 20, 2025, 8:05 AM EDT - 16 days ago

Guardant Health Introduces Hereditary Cancer Testing to Identify Inherited Predispositions to Certain Types of Cancer

May 8, 2025, 4:05 PM EDT - 4 weeks ago

Guardant Health to Participate in Upcoming Investor Conferences

May 8, 2025, 9:20 AM EDT - 4 weeks ago

TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List of the 100 Most Influential People in Global Health This Year

May 7, 2025, 5:05 PM EDT - 4 weeks ago

Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 1, 2025, 4:33 PM EDT - 5 weeks ago

Guardant Health: Tailwinds Are Beginning To Impact The Financials

Apr 30, 2025, 10:25 PM EDT - 5 weeks ago

Guardant Health, Inc. (GH) Q1 2025 Earnings Call Transcript

Apr 30, 2025, 4:05 PM EDT - 5 weeks ago

Guardant Health Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

Apr 29, 2025, 4:20 PM EDT - 5 weeks ago

Guardant Health Presents Data Demonstrating Strong Performance of Shield Multi-Cancer Detection Test Across 10 Tumor Types

Apr 28, 2025, 9:12 AM EDT - 5 weeks ago

CORRECTING and REPLACING Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer

Apr 28, 2025, 8:05 AM EDT - 5 weeks ago

Guardant Health Launches Guardant360 Tissue, First Tissue Molecular Profiling Test with Comprehensive Multiomic Analysis to Provide a More Complete View of Cancer

Apr 24, 2025, 8:05 AM EDT - 6 weeks ago

Guardant Health Announces Strategic Collaboration With Pfizer to Support Development and Commercialization of New Cancer Therapies Using Guardant Infinity Smart Liquid Biopsy Platform

PFE

Apr 22, 2025, 8:05 AM EDT - 6 weeks ago

Guardant Health to Present Data Highlighting Advances in Multi-Cancer Detection and Liquid and Tissue Molecular Profiling at AACR

Apr 10, 2025, 4:05 PM EDT - 2 months ago

Guardant Health to Report First Quarter 2025 Financial Results on April 30, 2025

Apr 3, 2025, 8:05 AM EDT - 2 months ago

Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada

Mar 25, 2025, 4:05 PM EDT - 2 months ago

Guardant Health's Shield Blood Test Now Covered for VA Community Care Beneficiaries

Mar 13, 2025, 7:51 AM EDT - 3 months ago

Guardant Health: Great Buy On Dips For Strong Diagnostics Verticals Despite Premium Valuation

Mar 11, 2025, 2:48 PM EDT - 3 months ago

Medicare To Reimburse Guardant Health's Shield Colorectal Cancer Test, Analyst Expects $10M In Revenue

Mar 11, 2025, 7:00 AM EDT - 3 months ago

Guardant Health Receives ADLT Status From CMS for Shield Blood Test

Feb 27, 2025, 8:05 AM EST - 3 months ago

New Guardant Health/Harris Poll Survey Highlights Patient Fear and Anxiety as Major Barriers to Colorectal Cancer Screening, but Blood Test Option Offers Hope for Change

Feb 21, 2025, 1:33 PM EST - 3 months ago

What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?

Feb 20, 2025, 11:14 PM EST - 3 months ago

Guardant Health, Inc. (GH) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 4:05 PM EST - 3 months ago

Guardant Health Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

Feb 13, 2025, 9:45 AM EST - 4 months ago

Guardant Health: Asymptomatic Screening Creating An Asymmetric Opportunity

Feb 7, 2025, 6:30 AM EST - 4 months ago

Guardant Health Announces Debt Exchange Transactions

Jan 30, 2025, 4:05 PM EST - 4 months ago

Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025

Jan 30, 2025, 8:05 AM EST - 4 months ago

Guardant Health's Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal Cancer Screening Program

Jan 23, 2025, 8:05 AM EST - 4 months ago

Guardant Health to Present Data at ASCO GI Demonstrating the Value of Its Precision Oncology Tools for Cancer Detection, Treatment Decisions and Therapy Development

Jan 21, 2025, 2:15 PM EST - 4 months ago

Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test

Jan 21, 2025, 8:05 AM EST - 4 months ago

Guardant Health Receives Medicare Coverage for Guardant Reveal™ on Smart Liquid Biopsy™ Platform for Surveillance Testing in Colorectal Cancer Patients

Jan 16, 2025, 8:05 AM EST - 5 months ago

Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development

Jan 14, 2025, 3:56 PM EST - 5 months ago

Viz.ai to Collaborate With Guardant Health to Improve Lung Cancer Detection, Diagnosis, and Treatment

Jan 13, 2025, 7:00 AM EST - 5 months ago

Guardant Health Announces Preliminary Fourth Quarter and Full Year 2024 Results

Jan 7, 2025, 8:03 AM EST - 5 months ago

Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute's Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection

Jan 2, 2025, 4:05 PM EST - 5 months ago

Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 20, 2024, 8:05 AM EST - 5 months ago

Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care

Dec 19, 2024, 6:00 AM EST - 6 months ago

COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics

Dec 18, 2024, 8:05 AM EST - 6 months ago

Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer

Dec 9, 2024, 8:05 AM EST - 6 months ago

Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium

Dec 4, 2024, 1:31 PM EST - 6 months ago

Guardant Health Stock Flashing Surefire ‘Buy' Signal

Nov 25, 2024, 5:09 PM EST - 6 months ago

Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™

NTRA

Nov 6, 2024, 9:53 PM EST - 7 months ago

Guardant Health, Inc. (GH) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 4:05 PM EST - 7 months ago

Guardant Health Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance